The Exchange has sought clarification from JB Chemicals & Pharmaceuticals with reference to the news appeared on www.moneycontrol.com ‘Companys Panoli tablet manufacturing facility gets inspected with zero 483 by US FDA.’
The above information is a part of company’s filings submitted to BSE.